CMIC HOLDINGS Co., Ltd.
世界中の誰もがより健康で その人らしい生活を送るため、ヘルスケアの革新に貢献します
CMIC HOLDINGS is a Japanese healthcare group whose Pharmaceutical Solutions cover consulting, non-clinical CRO, CRO, CDMO, SMO and CSO services. The group says it supports pharmaceutical companies across the value chain from non-clinical stages through post-marketing.
Services
About this organization
Overview
CMIC Group (シミックグループ) presents itself as a healthcare group that aims to contribute to healthcare innovation. Its corporate site describes three solution areas: Pharmaceutical Solutions, Healthcare Solutions and Specialized Solutions.
Pharmaceutical Solutions
- Consulting, Non-Clinical CRO, CRO, CDMO, SMO and CSO services.
- Positioned as an end-to-end solution covering the pharmaceutical value chain from non-clinical development through post-marketing.
Healthcare and specialized solutions
- Healthcare Solutions: digital health and municipal support solutions.
- Specialized Solutions: solutions tailored to the needs of patients and medical institutions.
Recent activity noted on the site
- Named a finalist in the Scrip Awards 2026 "Best CRO - Specialist Providers" category.
- Announced a joint venture, TriNebula Cell Tech, with Dai Nippon Printing and NEXEL, focused on global deployment of animal-alternative evaluation products.
Related companies
Similar profiles by shared services, modalities, and capabilities.
Viralgen- Regulatory Affairs
- US FDA Regulatory Strategy
Altasciences- Phase I Clinical Trials
- Phase II Clinical Trials
Pharmaron- Phase I Clinical Trials
- Phase II Clinical Trials
Syngene International- Phase I Clinical Trials
- Phase II Clinical Trials
uBriGene- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
Nuvisan- Phase I Clinical Trials
- Phase II Clinical Trials
ResolveMass Laboratories Inc.- Regulatory Affairs
- US FDA Regulatory Strategy
Rotop Pharmaka GmbH- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
Submit a verified review for this organization.
Markdown mirror: /companies/cmicgroup.md